EuropaBio – the European Association for Bioindustries is delighted to invite you to its first public SME BioForum event - “SME BioForum 2022 – the voice […]
Rare Disease Day takes place on February 28th across the globe to raise awareness among policymakers and the public about rare diseases and their impact on patient's lives and their families...
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem.
Event agenda 12:00: Registration opens 12:30: Panel starts 13:45: Panel close and networking lunch 15:00: Close Confirmed Speakers Tomislav Sokol MEPMember SANT Committee, European Parliament Hilde […]
Over the millennia science & technology have steadily advanced, but key unsolved challenges remain, and much more is possible. The Curious – Future Insight™ Conference brings […]
Europe is home to a vibrant community of Biotechnology SMEs contributing to the modernisation of the European industry. European biotechnology SMEs are the main drivers for […]
EuropaBio, the European association representing Bioindustries, will host an evening reception co-hosted by MEP Stine Bosse (Vice-Chair, SANT) and MEP Eszter Lakos (Member, ITRE), to discuss […]
EuropaBio is pleased to host its third Summit focused on biotechnology & biomanufacturing. Biotechnology is a critical technology for Europe. Delivery of innovation into market drives […]
Europe’s biotech sector continues to face significant financing challenges, especially during growth and scale‑up. As the EU moves forward with the landmark Biotech Act, this webinar […]
EuropaBio is joining BIO-Europe Spring 2026. BIO-Europe Spring is Europe's largest springtime biotech partnering event, bringing together over 3,700 leaders and innovators in the life sciences […]
Join our Director General Dr Claire Skentelbery at BIO-Europe Spring on the 23rd of March for an afternoon session dedicated to the EU Biotech Act Part […]
Join Director General Sandra Gallina and EuropaBio to explore the EU Biotech Act proposal, published in December 2025. The webinar explores the Goal of the Act, […]
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
